CRNX:NASDAQ
Crinetics Pharmaceuticals Inc
$32.92
arrow_downward
-4.94%(-1.71) 1D
$32.92
0.00% (0.00)
bedtimeAfter hours
Closed: Jun 5, 3:54:04 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CRNX...
Open
$34.65
High
$34.80
Low
$32.65
Mkt. cap
3.47B
Avg. vol.
1.26M
Volume
596.36K
52-wk high
$57.99
52-wk low
$25.83
EPS
-$5.13
Beta
0.24
Shares outstanding
105.44M
No. of employees
594
Open
$34.65
High
$34.80
Low
$32.65
Mkt. cap
3.47B
Avg. vol.
1.26M
Volume
596.36K
52-wk high
$57.99
52-wk low
$25.83
EPS
-$5.13
Beta
0.24
Shares outstanding
105.44M
No. of employees
594
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to CRNX in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CRNX in the last 3 months.
Highest
Current $32.92
$97.00 (+194.65%)
Average
$88.14 (+167.74%)
Lowest
$81.00 (+146.05%)
News stories
From sources across the web
Stock Titan
·
3 days ago
New Everyday Advocacy tools help endocrine patients navigate care
Stock Titan
·
3 days ago
Crinetics (NASDAQ: CRNX) CEO reports 1.94M share gifts and trust transfers
Profile
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018. Wikipedia
About Crinetics Pharmaceuticals Inc
AI content may include mistakes. Learn more